OOIR: Observatory of International Research

Papers

(The H4-Index of Drug Delivery and Translational Research is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Intranasal drug delivery: opportunities and toxicologic challenges during drug development	199
Nanotechnology-based antiviral therapeutics	154
Enhancement strategies for transdermal drug delivery systems: current trends and applications	148
Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives	99
Current hurdles to the translation of nanomedicines from bench to the clinic	93
Current approaches in lipid-based nanocarriers for oral drug delivery	80
Ultrasound-responsive polymer-based drug delivery systems	74
Clinical approval of nanotechnology-based SARS-CoV-2 mRNA vaccines: impact on translational nanomedicine	70
Polymeric micelles and cancer therapy: an ingenious multimodal tumor-targeted drug delivery system	59
Therapy of infected wounds: overcoming clinical challenges by advanced drug delivery systems	59
Exosomal targeting and its potential clinical application	58
Influencing factors and drug application of iontophoresis in transdermal drug delivery: an overview of recent progress	58
Emerging era of “somes”: polymersomes as versatile drug delivery carrier for cancer diagnostics and therapy	57
Atorvastatin-loaded solid lipid nanoparticles as eye drops: proposed treatment option for age-related macular degeneration (AMD)	57
Cyclodextrin-based delivery systems for in vivo-tested anticancer therapies	47
Inhalable solid lipid nanoparticles for intracellular tuberculosis infection therapy: macrophage-targeting and pH-sensitive properties	46
An overview of chitosan and its application in infectious diseases	46
PEI fluorination reduces toxicity and promotes liver-targeted siRNA delivery	45
Clinical translation of gold nanoparticles	44
Perspectives of characterization and bioconjugation of gold nanoparticles and their application in lateral flow immunosensing	44
Formulation and evaluation of cubosomes containing colchicine for transdermal delivery	44
Robotics, microfluidics, nanotechnology and AI in the synthesis and evaluation of liposomes and polymeric drug delivery systems	43
Development of vaccine formulations: past, present, and future	42
Formulation development of linagliptin solid lipid nanoparticles for oral bioavailability enhancement: role of P-gp inhibition	41
Treatment of Alzheimer’s diseases using donepezil nanoemulsion: an intranasal approach	41

Anacardic acid encapsulated solid lipid nanoparticles for Staphylococcus aureus biofilm therapy: chitosan and DNase coating improves antimicrobial activity	41
Rifampicin loaded in alginate/chitosan nanoparticles as a promising pulmonary carrier against Staphylococcus aureus	38
Recent advances in porous microneedles: materials, fabrication, and transdermal applications	38
Enhancement of skin permeability with thermal ablation techniques: concept to commercial products	38
Advanced trends in protein and peptide drug delivery: a special emphasis on aquasomes and microneedles techniques	37
A robotic pill for oral delivery of biotherapeutics: safety, tolerability, and performance in healthy subjects	37
Intranasal drug delivery for treatment of Alzheimer’s disease	36
QbD aided development of ibrutinib-loaded nanostructured lipid carriers aimed for lymphatic targeting: evaluation using chylomicron flow blocking approach	35
Phospholipid complex-loaded self-assembled phytosomal soft nanoparticles: evidence of enhanced solubility, dissolution rate, ex vivo permeability, oral bioavailability, and antioxidant potential of ma	34
Exploring the role of mesoporous silica nanoparticle in the development of novel drug delivery systems	34